Medicine – Product licence. The Court of Appeal, Civil Division, dismissed the claimant's appeal against the dismissal of judicial review proceedings, challenging the way the defendant Secretary of State, acting by the Medicines and Healthcare Products Regulatory Agency (the MHRA), had passed information to the European Medicines Agency under the European Union pharmacovigilance regime. The judge had correctly found that the MHRA had not acted unfairly and had rightly refused a reference to the Court of Justice of the European Union.